News
-
-
-
COMMUNIQUÉ DE PRESSE
Cyprumed Enters License and Option Agreement with MSD for the Development of Oral Peptide Therapeutics
Cyprumed and MSD sign a Non-Exclusive License and Option Agreement for the Development of Oral Peptide Therapeutics, potentially unlocking new opportunities in peptide therapeutics -
COMMUNIQUÉ DE PRESSE
EMERAM achieves success in challenging market environment: four investments and one exit in 2024, double-digit growth expected in 2025
EMERAM Capital Partners achieves success with four investments and one exit in 2024, predicts double-digit growth for 2025 amidst challenging market conditions -
-
-
-
-
COMMUNIQUÉ RÉGLEMENTÉ
Cie du Bois Sauvage : Rachat d’actions propres – semaine du 07/04/2025 au 11/04/2025
La Compagnie du Bois Sauvage annonce le rachat d'actions propres sur le marché réglementé NYSE Euronext Bruxelles du 07/04/2025 au 11/04/2025, conformément à l'autorisation de l'assemblée générale extraordinaire d'avril 2021 -
